Mycoses

Article	Citations
Author Index	62
Combined ImmunoCAP and Western Blot for the Diagnosis of Aspergillus Lung Disease	52
Intra‐Abdominal Candidiasis in Cancer Patients: A 10‐Year Experience in a Middle‐Income Country	52
	48
Physicians' knowledge of invasive fungal disease in China	46
Aspergillosis and Mucormycosis‐Associated Hospitalizations, United States, 2016–2021	46
T Cell Exhaustion and Function State Correlated With Outcomes in Patients With Intra‐Abdominal Candidiasis	37
Low toxicity contributes to Sporothrix globosa invade the skin of patients in low‐epidemic areas of China	36
Issue Information	35
Issue Information	34
High attenuation mucus in bronchi with allergic bronchopulmonary mycosis	34
Performance Evaluation of Five Real‐Time PCR Assays for the Detection of Candida aurisDNA	33
Review Article White Piedra: Review of 131 cases	31
Performance of the IMMY® sona Aspergillus lateral flow assay for the detection of galactomannan in tracheal aspirate samples from Brazilian patients with COVID‐19‐associat	28
T‐cell dysfunction as a potential contributing factor in post‐COVID‐19 mucormycosis	27
Multicenter Candida auris outbreak caused by azole‐susceptible clade IV in Pernambuco, Brazil	26
Diverse Colonisation and Disease Associations of the Human Commensal Malassezia: Our Body's Secret Tenant	26
Emergence of Candida auris in intensive care units in Algeria	25
The Importance of Early Mycological Clearance of Uncomplicated Candidaemia and Its Implications for Clinical Practice	24
Global Insights and Trends in Research on Dermatophytes and Dermatophytosis: A Bibliometric Analysis	24
Development of single‐tube real‐time PCR assay for the rapid detection of Aspergillus and Fusarium—The two most common causative agents in fungal keratitis	24
Issue Information	22
Issue Information	22
Efficacy of Amorolfine in Onychomycosis Treatment: A Mixed‐Effects Models and Multivariate Logistic Regression Analysis	21
Comparison of dermoscopic characteristics on toenail onychomycosis in psoriatic and non‐psoriatic patients: A prospective study	21

Combination therapy with itraconazole and terbinafine for phaeohyphomycosis caused by Exophiala spinifera: A case report and literature review	20
Cover Image	20
Update of the Epidemiology of the Sporotrichosis Epidemic in the state of Rio Grande do Sul, Brazil	20
Pan‐azole‐resistant Meyerozyma guilliermondii clonal isolates harbouring a double F126L and L505F mutation in Erg11	20
ESCMID‐EFISG Survey on Diagnostic and Therapeutic Capacity for Invasive Fungal Infections in Belgium, the Netherlands, and Luxembourg: A Focus on High Azole Resistance	19
Evaluating the Potential of Galactosaminogalactan as a Diagnostic Target for Invasive Aspergillosis	19
Utility and Pitfalls of β‐D‐Glucan for Diagnosis and Response Monitoring of Chronic Disseminated Candidiasis in Paediatric Cancer Patients	19
Active screening of COVID‐19‐associated pulmonary aspergillosis with serum beta‐glucan and endotracheal aspirates galactomannan and fungal culture	19
Corrections to “Epidemiology of Vulvovaginal Candidiasis in Greece: A 2‐Year Single‐Centre Study”	18
Comparative Analysis of Chemiluminescence Immunoassay (CLIA)‐Based Tests in the Diagnosis of Invasive Aspergillosis in Patients With Hematologic Malignancies	18
Optimization of a commercial Histoplasma galactomannan EIA test in a population from an endemic area of histoplasmosis in southern Brazil	18
Issue Information	18
Machine‐learning‐based virtual screening to repurpose drugs for treatment of Candida albicans infection	18
	18
Analysis of Susceptibility and Drug Resistance of Antifungal Agents in Aspergillosis and Mucormycosis Patients: A Systematic Review	17
Eumycetoma causative agents are inhibited in vitro by luliconazole, lanoconazole and ravuconazole	17
Characterisation of Antifungal Resistance to Azoles in Colombian Isolates of Malassezia spp.	17
Children onychomycosis, a neglected dermatophytosis: A retrospective study of epidemiology and treatment	17
Diode Laser and Red‐Laser Photodynamic Therapy Versus Ciclopirox 8% HPCH Nail Lacquer for the Treatment of Onychomycosis: A Randomised Controlled Tri	16
Optimisation of a Murine Infection Model With Trichophyton mentagrophytes for Studying the Pathogenesis of Dermatophytosis	16
	16
The Paediatric European Confederation of Medical Mycology (ECMM) Quality (Paed‐EQUAL) Candida Score for the Management of Candidaemia in Children and Neonates	16
A screening study for COVID‐19‐associated pulmonary aspergillosis in critically ill patients during the third wave of the pandemic	16
Prototype early diagnostic model for invasive pulmonary aspergillosis based on deep learning and big data training	16
Diagnostic performance of noncultural methods for central nervous system aspergillosis	15
CARD9 mutations in patients with fungal infections: An update from the last 5 years	15
Tinea pedis in underrepresented groups: All of Us database analysis	15
Prevalence, genetic diversity and antifungal susceptibility profiles of F. fujikuroi, F. solani and Fusarium incarnatum‐equiseti species complexes from onychomycosis in north of I	15
Aspergillus‐PCR in bronchoalveolar lavage ‐ diagnostic accuracy for invasive pulmonary aspergillosis in critically ill patients	15
Comparative analysis of galactomannan lateral flow assay, galactomannan enzyme immunoassay and BAL culture for diagnosis of COVID‐19‐associated pulmonary aspergillosis	15
Species Distinction in the Trichophyton mentagrophytes Complex Based on Phylogenomic Analysis	15
	14
	14
Epidemiological patterns of candidaemia: A comprehensive analysis over a decade	14
Mucormycosis caused by Apophysomyces species: An experience from a tertiary care hospital in Western India and systematic review of global cases	14
	14
Gradient diffusion strips for detecting azole resistance in Aspergillus fumigatus sensu lato	14
Emergence of zoonotic sporotrichosis due to Sporothrix brasiliensis in Minas Gerais, Brazil: A molecular approach to the current animal disease	13
Challenges towards management of CARD9‐deficient patients with phaeohyphomycosis: A case report and case series study	13
Modified Tinea Corporis Score (mTCS) Versus Tinea Corporis Score (TCS): A Comparative, Noninterventional Validation Study	13
Treatment of the Candida subspecies Candida albicans and Candida parapsilosis with two far‐UVC sources to minimise mycoses in clinical practice	13
Screening Candida auris through a multiplex stepwise PCR algorithm directly from clinical samples of patients suspected of otomycosis in south of Iran; Detection of five cases	13
Histoplasma antigen detection in unconfirmed pulmonary tuberculosis and cross‐reactivity with Aspergillus antigen in patients and in food in Jakarta, Indonesia	13
EQUAL ABPA Score 2024: A Tool to Measure Guideline Adherence for Managing Allergic Bronchopulmonary Aspergillosis	13
Chinese expert consensus on management of antifungal‐resistant dermatophytoses (2024 edition)	12
Performance of existing clinical scores and laboratory tests for the diagnosis of invasive candidiasis in critically ill, nonneutropenic, adult patients: A systematic review with qualitative evidence	12
Chronic pulmonary aspergillosis in patients with active pulmonary tuberculosis with persisting symptoms in Uganda	12
Azole resistance in Aspergillus fumigatus. The first 2‐year's Data from the Danish National Surveillance Study, 2018–2020	12
The Role of Histopathological Examination in the Diagnosis of Cutaneous Sporotrichosis Caused by Sporothrix globosa: A Retrospective Analysis and Reassessment	12
Subtilisin 6 From the Dermatophyte Trichophyton benhamiae Is a Marker of Infection but Not a Unique Virulence Factor	12

Zoonotic and Anthropophilic Trichophyton mentagrophytes Complex Infection in Human: An Update and Narrative Review	12
Virulence of Candida spp. Isolates From Patients With Recurrent Vulvovaginal Candidosis Is Associated With the Number of Episodes	11
Epidemiology of Vulvovaginal Candidiasis in Greece: A 2‐Year Single‐Centre Study	11
	11
Genotypic Diversity and Molecular Basis of Fluconazole Resistance in Candida parapsilosis Clinical Isolates Collected Over 7 Years in a Tertiary‐Care Hospital in North India	11
	11
Application of machine learning for mortality prediction in patients with candidemia: Feasibility verification and comparison with clinical severity scores	11
Dermatophytosis and the associated risk factors among primary school children in southern and central Côte d'Ivoire	11
Epidemiology and Pathogen Shift of Tinea Capitis: A Comparative Analysis of Adults and Children in Nanchang, China (2022–2024)	11
Isolated tracheobronchial mucormycosis: Report of a case and systematic review of literature	10
Lower beta‐1,3‐D‐glucan testing cut‐offs increase sensitivity for non‐albicans Candida species bloodstream infections	10
Effect of volume of instillate on the diagnostic utility of bronchoalveolar lavage galactomannan in patients with suspected chronic pulmonary aspergillosis—A pilot study	10
A clinical prevalence of dermatophytic mycoses with an assessment of its clinical manifestations in a tertiary care hospital at Salem, South India	10
	10
Biologic Therapy and Superficial Fungal Infection Risk in Moderate‐to‐Severe Psoriasis: A Meta‐Analysis	10
Evaluation of the Post‐Antifungal Effect of Rezafungin and Micafungin against Candida albicans, Candida parapsilosis and Candida glabrata	10
Onychomycosis due to Fusarium species in different continents, literature review on diagnosis and treatment	10
The In Vitro Activity of Rezafungin Against Uncommon Species of Candida	10
Multimodal analysis of the COVID‐19‐associated mucormycosis outbreak in Delhi, India indicates the convergence of clinical and environmental risk factors	10
A systematic review and meta‐analysis of efficacy and safety of isavuconazole for the treatment and prophylaxis of invasive fungal infections	10
Emerging subcutaneous mycoses by opportunistic filamentous fungi: A retrospective study in Northwest Spain	10
Epidemiology of Triazole Resistant Aspergillus fumigatus in Asia: A Systematic Review and Meta‐Analysis	10
Revisiting the pathogenesis of dermatophytosis: A cross‐sectional analytic study of serum levels of interleukins‐2, 8, 10 and 17	10
Issue Information	9
Improving Diagnostic Sensitivity of Chronic Pulmonary Aspergillosis Using Species‐Specific IgG	9
Expert recommendations for prevention and management of Candida auris transmission	9
Clinico‐mycological validation of dermatophytosis severity score and its correlation with patient‐reported outcome measures	9
Serological Response and Associated Prognostic Factors in Paracoccidioidomycosis: A 15‐Year Retrospective Study	9
Correction to Nd:YAG 1064 nm laser treatment for onychomycosis—Is it really effective? A prospective assessment for efficiency and factors contributing to response	9
Clinical Significance of Aspergillus Sensitisation in Chronic Pulmonary Aspergillosis	9
	9
When and how do we stop antifungal treatment for an invasive mould infection in allogeneic haematopoietic cell transplant recipients?	9
Fungal Disease Response Centre: Pioneering Diagnostic Approach for Regions With Dispersed Hospital Centres	9
Aspergillus nodules: Natural history and the effect of antifungals	9
Global Emergence of Antifungal‐Resistant Dermatophytosis Caused by Trichophyton indotineae (Formerly T. mentagrophytesITS Genotype VIII): A Genomic Investigation In	9
Tropicoporus tropicalis: A Newly Recognised Pathogen in Eumycetoma and Refractory Mycoses in Humans	9
Morbidity and mortality of hospitalised patients with candidemia during the various severe acute respiratory syndrome coronavirus 2 pandemic waves: A multicentre evaluation of 248 US hospit	9
Microbiological culture combined with PCR for the diagnosis of onychomycosis: Descriptive analysis of 121 patients	8
Natural history and prognostic factors of candidemia in kidney transplant recipients: A retrospective, multinational study	8
Clinical Characteristics, Radiological, and Outcomes of Mucormycosis: A 14‐Year Retrospective Study From Southern China	8
Usefulness of 18F‐FDG PET‐CT for the management of invasive fungal infections: A retrospective cohort from a tertiary university hospital	8
Is there still a place for serum galactomannan in the diagnosis of invasive aspergillosis in children at high risk and under antifungal prophylaxis?	8
Clinical characteristics and risk factors for late‐onset pneumocystis jirovecii pneumonia in kidney transplantation recipients	8
Coccidioidomycosis in Oklahoma: A retrospective case series	8
Cryptococcosis in the Democratic Republic of Congo from 1953 to 2021: A systematic review and meta‐analysis	8
Exploring the clinical features and risk factors for children tinea capitis complicated with allergic diseases	8
Secondary invasive fungal infection in hospitalised patients with COVID‐19 in the United States	8
Saksenaea vasiformis infection: Extensive abdominal wall necrotizing fasciitis with systematic review and analysis of 65 cases	8
Updated estimation of the burden of fungal disease in Vietnam	8
A retrospective Italian analysis on the characteristics of invasive fungal infections in the intensive care unit setting: CHARTER‐IFI study	8
Retrospective Epidemiology of Dermatomycosis in Kinshasa, Democratic Republic of Congo, From 2000 to 2023	8
Therapeutic drug monitoring of posaconazole delayed release tablet while managing COVID‐19–associated mucormycosis in a real‐life setting	8
Current situation of endemic mycosis in the Americas and the Caribbean: Proceedings of the first international meeting on endemic mycoses of the Americas (IMEMA)	8
Risk factors for pulmonary mucormycosis in subjects with diabetes mellitus—A case‐control study	8
Mechanism of azole resistance in Candida vulturna, an emerging multidrug resistant pathogen related with Candida haeumulonii and Candida auris	7
Sensitivity and Specificity of Plasma and Bronchoalveolar Lavage Fluid PCR for Diagnosing Pulmonary Mucormycosis in Subjects With Diabetes Mellitus	7
Exploring the intersection of Aspergillus fumigatus biofilms, infections, immune response and antifungal resistance	7
Let's talk about sex characteristics—As a risk factor for invasive fungal diseases	7
Activity of amorolfine or ciclopirox in combination with terbinafine against pathogenic fungi in onychomycosis—Results of an in vitro investigation	7
Abstracts	7
A New Medium That Promotes Mass Sporulation of Trichophyton rubrum In Vitro	7
Inter‐observer reliability of the Onychomycosis Severity Index depending on clinical experience: A review of 50 cases	7
The prognostic factors for cryptococcal meningitis in non‐human immunodeficiency virus patients: An observational study using nationwide database	7
Issue Information	7
Time and cost‐efficient identification of Trichophyton indotineae	7
Candida albicans skin infection in diabetic patients: An updated review of pathogenesis and management	7
Inter‐Hospital Spread of Fluconazole‐Resistant C. parapsilosis in Northern Italy: Insights Into Clonal Distribution, Resistance Mechanisms and Biofilm Production	7
Trichophyton Quinckeanum: Renaissance of the Mouse Favus Pathogen in Central Germany	7
Global, regional, and national burden of fungal skin diseases in 204 countries and territories from 1990 to 2021: An analysis of the global burden of disease study 2021	7
Mucormycosis in Africa: Epidemiology, diagnosis and treatment outcomes	7
The First Isolation of Multiple Antifungal‐Drug‐Resistant Trichophyton Rubrum in China and the Novel Resistance Mechanism	7
Paediatric cutaneous mucormycosis: A case report and review of the literature	7
Issue Information	7
Candida Infective Endocarditis in Patients With Candida spp. Bloodstream Infection: Risk Factors and 1‐ Year Mortality	7
As the virus sowed, the fungus reaped! A comparative analysis of the clinico‐epidemiological characteristics of rhino‐orbital mucormycosis before and during COVID‐19 pandemic	7
	6
	6
Multicentre Study of Candida parapsilosis Blood Isolates in Türkiye Highlights an Increasing Rate of Fluconazole Resistance and Emergence of Echinocandin and Multidrug Resistance	6
Incidence of invasive fungal diseases in inflammatory bowel disease patients: A nationwide study in South Korea	6
Dermatophytes and skin dermatophytoses in Southeast Asia—First epidemiological survey from Cambodia	6

	6
Issue Information	6
In Vitro Activity of Nitroxoline (5‐Nitro‐8‐Hydroxyquinoline) Against Aspergillus Species	6
Susceptibility patterns of amphotericin B, itraconazole, posaconazole, voriconazole and caspofungin for isolates causing invasive mould infections from the SENTRY Antifungal Surveillance Pr	6
Epidemiological and Clinical Profile Analysis of Trichophyton mentagrophytesITS Genotype VII Infected Dermatomycosis: An Emerging Sexually Transmitted Pathogen	6
Invasive fungal infection incidence and risk factors in patients receiving ibrutinib in real‐life settings: A nationwide population‐based cohort study	6
Genotypic diversity and antifungal susceptibility of Scedosporium species from clinical settings in China	6
Issue Information	6
Immune and metabolic perturbations in COVID‐19‐associated pulmonary mucormycosis: A transcriptome analysis of innate immune cells	6
Altered skin fungal and bacterial community compositions in tinea capitis	6
Airway Mycobiota—Microbiota During Pulmonary Exacerbation of Cystic Fibrosis Patients: A Culture and Targeted Sequencing Study	6
	6
First Reported Cases of Terbinafine‐Resistant Trichophyton indotineae Isolates in Israel: Epidemiology, Clinical Characteristics and Response to Treatment	6
Clinical Characteristics and Outcomes in Patients With Cryptococcaemia From a Large Population‐Based Cohort	6
A clinicoepidemiological study on tinea incognita with assessment of its treatment strategies and drug prescribing practices in a tertiary care hospital	6
Antibody Isotype and Subclass Responses in Human Patients With Different Clinical Presentations of Sporotrichosis	6
Increasing and Alarming Prevalence of Trichophyton indotineae as the Primary Causal Agent of Skin Dermatophytosis in Iran	6
Real‐world effectiveness of antifungal prophylaxis with posaconazole as the primary agent in patients with haematological malignancies	6
Performance of the clarus Aspergillus galactomannan enzyme immunoassay prototype for the diagnosis of invasive pulmonary aspergillosis in serum	6
	6
Deep Learning Models for CT Segmentation of Invasive Pulmonary Aspergillosis, Mucormycosis, Bacterial Pneumonia and Tuberculosis: A Multicentre Study	6
Issue Information	6
	5
Understanding Global Access to Topical Onychomycosis Therapy: A Systematic Review and Meta‐Analysis	5
Role of recombinant Histoplasma capsulatum 100‐kilodalton antigen in the diagnosis of histoplasmosis among HIV/AIDS patients: Antigenuria and antibodies detection	5
	5
Aetiology of tinea of vellus hair and substrate specificity in Microsporum species	5
Pharmacies Counselling of Patients in the Era of Antifungal Resistance	5
Clinical and demographic factors affecting trough levels of isavuconazole in critically ill patients with or without COVID‐19	5
Effect of Antifungal Therapy on the Postoperative Period in Non‐Invasive Fungal Sinusitis: A Systematic Review and Meta‐Analysis	5
	5
Chromoblastomycosis: A Single Centre Clinical Laboratory Experience of Seven Years (2016–2022) and Literature Review From Pakistan	5
Application of deep learning algorithm in the recognition of cryptococcosis and talaromycosis skin lesions	5
Contribution of voriconazole N‐oxide plasma concentration measurements to voriconazole therapeutic drug monitoring in patients with invasive fungal infection	5
Antifungal susceptibility of the clinical and environmental strains of Cryptococcus gattii sensu lato in Taiwan	5
Early Candida colonisation impact on patients and healthcare professionals in an intensive care unit	5
Prevalence and Antifungal Susceptibility of Sporothrix species in Guangzhou, Southern China	5
In memoriam: Professor Dieter Buchheidt, MD, PhD, FECMM (1955‐2021)	5
Incidence of Coronavirus Disease 2019‐Associated Pulmonary Aspergillosis and Specialist Involvement in Its Diagnosis in Japan: A Nationwide Survey and Literature Review	5
The Effect of Topical Ketoconazole and Topical Miconazole Nitrate in Modulating the Skin Microbiome and Mycobiome of Patients With Tinea Pedis	5
Terbinafine Resistance in Trichophyton Species From Patients With Recalcitrant Infections Detected by the EUCAST Broth Microdilution Method and DermaGenius Resistance Mult	5
Issue Information	5
Risk factors associated with fluconazole resistance in Candida parapsilosis candidemia: A case–case study	5
Incidence and risk factors for COVID‐19 associated candidemia (CAC) in ICU patients	5
Isavuconazole therapeutic drug monitoring in critically ill ICU patients: A monocentric retrospective analysis	5
Development and validation of COVID‐19 associated candidemia score (CAC‐Score) in ICU patients	5
	5
Issue Information	5
Issue Information	5
Comparison of the Equivalence of Aspergillus Antigen and PCR Results Between Non‐Directed Bronchial Lavage and Bronchoalveolar Lavage—A Prospective Exploratory Pilot Study in Critica	5
Fluconazole‐resistant Candida parapsilosis genotypes from hospitals located in five Spanish cities and one in Italy: Description of azole‐resistance profiles associated with the Y132F ERG1	5
Tinea capitis caused by Trichophyton tonsurans among adults: Clinical characteristics and treatment response	5
Erratum	5
Issue Information	5
Cytomegalovirus viral interleukin‐10 in patients with Aspergillus infection and effects on clinical outcome	5
Effectiveness of FastFung agar in the isolation of Malassezia furfur from skin samples	5
Epidemiology, clinical presentation and management of COVID‐19 associated mucormycosis: A single centre experience from Pune, Western India	5
Comparison of features and outcomes between HIV‐negative patients with Cryptococcus gattii meningitis and Cryptococcus neoformans meningitis in South China	5
Comparison of liposomal amphotericin B alone and in combination with flucytosine in the treatment of non‐HIV Cryptococcal meningitis: A nationwide observational study	5
Rapid detection of dermatophytes using the Seegene Novaplex™ dermatophyte assay	5
Potential emergence of terbinafine resistance by squalene epoxidase gene mutations: An 18‐month cohort study of onychomycosis patients in the United States	5
Supervised training models with or without manual lesion delineation outperform clinicians in distinguishing pulmonary cryptococcosis from lung adenocarcinoma on chest CT	5
In vitro antifungal susceptibility profile of Iranian Fusarium isolates: Emphasising on the potent inhibitory effect of efinaconazole compared to other drugs	5
Hyperthermia is a promising potential adjunct to treating sporotrichosis: A refractory case of HIV sporotrichosis and in vitro experiments on Sporothrix spp.	5
The Aspergillus galactomannan Ag VIRCLIA® Monotest and the sõna Aspergillus galactomannan lateral flow assay show comparable performance for the diagnosis of invasive aspergil	5
Factors associated with pityriasis versicolor in a large national database	5
Nikkomycin Z for the treatment of experimental sporotrichosis caused bySporothrix brasiliensis	5
Development and Validation of an Explainable Machine Learning Model for Predicting Invasive Fungal Infection in Acute‐On‐Chronic Liver Failure Within 28 Days	4
	4
What to expect when AGEP is induced by terbinafine? Case report and critical review of the literature	4
A systematic review and disability‐adjusted life years of Scedosporium/Lomentospora infection in patients after near‐drowning	4
Continuous dosing of nikkomycin Z against systemic candidiasis, in vivo and in vitro correlates	4
Issue Information	4
Analysis of 15 cases from a monocentric cohort of 307 liver abscesses	4
Green natural nail polish modified with essential oils to treat onychomycosis	4
Is Antifungal Prophylaxis Needed for Acute Myeloid Leukaemia Patients Treated With Venetoclax‐Based Regimens? A Systematic Review and Meta‐Analysis	4
Approaches to Invasive Fungal Diseases in Paediatric Cancer Centres: An Analysis of Current Practices and Challenges in Germany, Austria and Switzerland	4
Comparative evaluation of host immune response and cytokine signature pertaining to Th1 and Th2 immune arms in serum and tissue among patients of acute localised vs. chronic disseminated de	4
New insights into development and mortality of COVID‐19‐associated pulmonary aspergillosis in a homogenous cohort of 1161 intensive care patients	4
Fungal Skin Disease Incidence, Prevalence and Disability‐Adjusted Life Years in Four Asian Countries (1990–2019)	4
Exome Sequencing of a Blastomycosis Case–Control Cohort From Manitoba and Northwestern Ontario, Canada	4
Issue Information	4
Effect of the implementation of clinical guidelines on management of candidemia in elderly patients	4
	4
Disease burden and demographic characteristics of mucormycosis: A nationwide population‐based study in Taiwan, 2006–2017	4
Issue Information	4
Clinical Characteristics and Genomic Analysis of a Trichophyton indotineae Strain Resistant to Terbinafine and Fluconazole Isolated in Italy	4
Issue Information	4
Dihydroorotate dehydrogenase inhibitor olorofim has potent in vitro activity against Microascus/Scopulariopsis, Rasamsonia, Penicillium and Talaromyces species	4
Efficacy and Safety of Rezafungin Versus Caspofungin for the Treatment of Candidemia and Invasive Candidiasis in a China Cohort of a Double‐Blind, Randomised, Phase 3 Trial (	4
Evaluation of Currently Available Laboratory Methods to Detect Terbinafine Resistant Dermatophytes Including a Gradient Strip for Terbinafine, EUCAST Microdilution E.Def 11.0, a Commercial	4
Multi‐state evaluation of Candida infections in burn patients	4
Antifungal use via outpatient parenteral antimicrobial therapy	4
Utility of MALDI‐ToF MS for Recognition and Antifungal Susceptibility of Nannizzia, an Underestimated Group of Dermatophytes	4
Global Burden of Fungal Skin Diseases and Future Projections: An Analysis of the 2021 Global Burden of Disease Study	4